BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32442409)

  • 1. An Integrated Deep-Mutational-Scanning Approach Provides Clinical Insights on PTEN Genotype-Phenotype Relationships.
    Mighell TL; Thacker S; Fombonne E; Eng C; O'Roak BJ
    Am J Hum Genet; 2020 Jun; 106(6):818-829. PubMed ID: 32442409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
    Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
    JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
    Smith IN; Thacker S; Jaini R; Eng C
    J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships.
    Mighell TL; Evans-Dutson S; O'Roak BJ
    Am J Hum Genet; 2018 May; 102(5):943-955. PubMed ID: 29706350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer.
    Smith IN; Thacker S; Seyfi M; Cheng F; Eng C
    Am J Hum Genet; 2019 May; 104(5):861-878. PubMed ID: 31006514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.
    Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF
    Fam Cancer; 2014 Mar; 13(1):57-63. PubMed ID: 23934601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
    Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
    Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial genome as a modifier of autism versus cancer phenotypes in
    Wei R; Yehia L; Ni Y; Eng C
    HGG Adv; 2023 Jul; 4(3):100199. PubMed ID: 37216009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating thousands of PTEN variant activity and abundance measurements reveals variant subgroups and new dominant negatives in cancers.
    Matreyek KA; Stephany JJ; Ahler E; Fowler DM
    Genome Med; 2021 Oct; 13(1):165. PubMed ID: 34649609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening.
    Marchese M; Conti V; Valvo G; Moro F; Muratori F; Tancredi R; Santorelli FM; Guerrini R; Sicca F
    BMC Med Genet; 2014 Feb; 15():26. PubMed ID: 24580998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome.
    Yehia L; Ni Y; Feng F; Seyfi M; Sadler T; Frazier TW; Eng C
    Am J Hum Genet; 2019 Oct; 105(4):813-821. PubMed ID: 31564436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism.
    Frazier TW; Jaini R; Busch RM; Wolf M; Sadler T; Klaas P; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C;
    Mol Autism; 2021 Jan; 12(1):5. PubMed ID: 33509259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral change.
    Busch RM; Frazier Ii TW; Sonneborn C; Hogue O; Klaas P; Srivastava S; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C
    J Neurodev Disord; 2023 Jan; 15(1):3. PubMed ID: 36641436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephaly.
    Wong CW; Or PMY; Wang Y; Li L; Li J; Yan M; Cao Y; Luk HM; Tong TMF; Leslie NR; Lo IF; Choy KW; Chan AML
    Autism Res; 2018 Aug; 11(8):1098-1109. PubMed ID: 29608813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Spectrum of
    Yehia L; Keel E; Eng C
    Annu Rev Med; 2020 Jan; 71():103-116. PubMed ID: 31433956
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes.
    Spinelli L; Black FM; Berg JN; Eickholt BJ; Leslie NR
    J Med Genet; 2015 Feb; 52(2):128-34. PubMed ID: 25527629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathogenic role for germline PTEN variants which accumulate into the nucleus.
    Mingo J; Rodríguez-Escudero I; Luna S; Fernández-Acero T; Amo L; Jonasson AR; Zori RT; López JI; Molina M; Cid VJ; Pulido R
    Eur J Hum Genet; 2018 Aug; 26(8):1180-1187. PubMed ID: 29706633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.
    Butler MG; Dasouki MJ; Zhou XP; Talebizadeh Z; Brown M; Takahashi TN; Miles JH; Wang CH; Stratton R; Pilarski R; Eng C
    J Med Genet; 2005 Apr; 42(4):318-21. PubMed ID: 15805158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.